dipyridamole has been researched along with Carcinoma 256, Walker in 11 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole is a non-specific inhibitor of nucleoside transport into mammalian cells." | 1.27 | The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the rat. ( Calvert, AH; Harrap, KR; Newell, DR; O'Connor, PM, 1986) |
| "Uridine transport in a variant (NRM) of Novikoff hepatoma cells, in HTC rat hepatoma cells, normal rat kidney (NRK) cells, rat erythrocytes and rat hepatocytes was inhibited 15-60% by 10-500 nM NBTI and the cells expressed high-affinity NBTI-binding sites (Kd = 0." | 1.27 | Nitrobenzylthioinosine-sensitive and -resistant nucleoside transport in normal and transformed rat cells. ( Plagemann, PG; Wohlhueter, RM, 1985) |
| "The mechanism of the early stage of metastasis formation by sticky blood-born cancer cells is discussed." | 1.26 | Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis. ( Gastpar, H, 1977) |
| "Dipyridamole and ancrod pretreatment did not influence the decrease of platelets and their accumulation in the lung after tumour cell injection." | 1.25 | The role of blood platelets in experimental metastases. ( Hilgard, P, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gastpar, H | 6 |
| Weissgerber, PW | 1 |
| Ambrus, JL | 1 |
| Ambrus, CM | 1 |
| Crawford, CR | 1 |
| Belt, JA | 2 |
| Noel, LD | 1 |
| Newell, DR | 1 |
| O'Connor, PM | 1 |
| Calvert, AH | 1 |
| Harrap, KR | 1 |
| Plagemann, PG | 1 |
| Wohlhueter, RM | 1 |
| Hilgard, P | 1 |
11 other studies available for dipyridamole and Carcinoma 256, Walker
| Article | Year |
|---|---|
The inhibition of cancer cell stickiness: a model for investigation of platelet aggregation inhibitors in vivo. V. The effect of penbutolol.
Topics: Animals; Carcinoma 256, Walker; Cell Aggregation; Chemical Phenomena; Chemistry; Depression, Chemica | 1981 |
Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations.
Topics: Animals; Bencyclane; Blood Coagulation; Carcinoma 256, Walker; Depression, Chemical; Dipyridamole; D | 1981 |
Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis.
Topics: Animals; Bencyclane; Blood Coagulation; Carcinoma 256, Walker; Cell Adhesion; Dipyridamole; Dissemin | 1977 |
[Inhibition of the "cancer cell stickiness" using pentoxyphylline (Trental)].
Topics: Animals; Blood Coagulation; Carcinoma 256, Walker; Dipyridamole; Dose-Response Relationship, Drug; K | 1976 |
Sodium-dependent, concentrative nucleoside transport in Walker 256 rat carcinosarcoma cells.
Topics: Animals; Biological Transport; Carcinoma 256, Walker; Dipyridamole; Formycins; Inosine; Kinetics; Nu | 1991 |
Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells. Differences in sensitivity to nitrobenzylthioinosine and thiol reagents.
Topics: 4-Chloromercuribenzenesulfonate; Animals; Biological Transport; Carcinoma 256, Walker; Cell Line; Di | 1985 |
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the rat.
Topics: Animals; Binding Sites; Blood Proteins; Bone Marrow; Carcinoma 256, Walker; Digestive System; Dipyri | 1986 |
Nitrobenzylthioinosine-sensitive and -resistant nucleoside transport in normal and transformed rat cells.
Topics: Animals; Binding Sites; Biological Transport; Carcinoma 256, Walker; Dipyridamole; Inosine; Kidney; | 1985 |
The role of blood platelets in experimental metastases.
Topics: Animals; Blood Cell Count; Blood Platelets; Carcinoma 256, Walker; Chromium; Chromium Isotopes; Dipy | 1973 |
Inhibition of cancer cell stickiness by the blocking of platelet aggregation.
Topics: Adhesiveness; Animals; Antineoplastic Agents; Blood Cell Count; Blood Platelets; Capillaries; Carcin | 1974 |
The inhibition of the cancer stickiness by pyrimido-pyrimidine derivates induced by inhibition of platelet aggregation.
Topics: Animals; Blood Platelets; Carcinoma 256, Walker; Cell Aggregation; Dipyridamole; Injections, Intrave | 1971 |